The Global Allergy Diagnostics Market is valued at US$ 5.92 Billion in 2025 and is forecast to reach US$ 10.36 Billion by 2031, growing at a CAGR of 9.8% (2026-2031), driven by rising allergy prevalence, expanding reimbursement, and adoption of multiplex immunoassay platforms.
North America is the largest market with a 38% share in 2025, led by the United States at US$ 1.85 billion across 17 profiled countries. Asia Pacific is the fastest-growing region, expanding at a CAGR above 12% as China and India scale diagnostic infrastructure.
In vitro specific-IgE immunoassays account for 58% of test-type revenue in 2025; reagents and kits represent 52% of product/service spend; serum/plasma-based sample collection leads at 68% of in vitro test volume.
The market spans 15 profiled companies; Thermo Fisher Scientific, Siemens Healthineers and Danaher Corporation together account for roughly 47.8% of 2025 revenue, with the remainder split across specialist and regional players.
Component-resolved diagnostics, AI-assisted result interpretation, and at-home/direct-to-consumer testing are set to reshape the competitive and product landscape through 2031, favoring platform vendors with molecular and digital capabilities.
North America is the largest market with a 38% share in 2025, led by the United States at US$ 1.85 billion across 17 profiled countries. Asia Pacific is the fastest-growing region, expanding at a CAGR above 12% as China and India scale diagnostic infrastructure.
In vitro specific-IgE immunoassays account for 58% of test-type revenue in 2025; reagents and kits represent 52% of product/service spend; serum/plasma-based sample collection leads at 68% of in vitro test volume.
The market spans 15 profiled companies; Thermo Fisher Scientific, Siemens Healthineers and Danaher Corporation together account for roughly 47.8% of 2025 revenue, with the remainder split across specialist and regional players.
Component-resolved diagnostics, AI-assisted result interpretation, and at-home/direct-to-consumer testing are set to reshape the competitive and product landscape through 2031, favoring platform vendors with molecular and digital capabilities.
Table of Contents
1. Introduction & Report Scope
2. Global Allergy Diagnostics Market Segmentation
3. Global Allergy Diagnostics Market Analysis
4. Regional Allergy Diagnostics Market Analysis
5. Competitive Landscape
6. Company Profiles
7. Market Dynamics
8. Strategic Outlook
Table of Figures
